Dennis Langer, Director at Quoin Pharmaceuticals, Ltd. (QNRX), bought 30,304 shares at $8.49 ($257K) on 2025-10-14, disclosed to the SEC on 2025-10-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.49 | 15,152 | $129K | 50.0% |
| 2 | $8.49 | 15,152 | $129K | 50.0% |
| Total | $8.49 avg | 30,304 | $257K | 100% |
| Filing → |
| DRNA | SELL | 2018-08-17 | $613K | — | Filing → |
| MYGN | SELL | 2018-06-08 | $1.6M | — | Filing → |
| MYGN | SELL | 2018-06-05 | $2.0M | — | Filing → |